Viking Therapeutics Stock No-Brainer: Is It Worth Buying Below $35?
Viking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
Learn about wealth building investment strategies that can help you achieve long-term financial success. Start investing wisely now.
21,459 articlesViking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
A billionaire’s online rant against a respected paper can ripple through markets and wallets. This article explains w...
A major hedge fund liquidated its GitLab position, prompting questions about strategy and market impact. This article...
The AI infrastructure boom has Nvidia leading, but Alphabet's end-to-end AI stack and TPU ecosystem could reshape the...
Nvidia delivers a standout quarter powered by AI demand, surpassing estimates and lifting guidance. This article brea...
Set up your weekend with a curated mix of Friday reads for investors. This guide rounds up 10 must-check pieces that ...
A bold claim from a veteran tech analyst puts SpaceX at the center of an AI-enabled future. This guide breaks down wh...
Remote work demand worldwide is shifting how companies hire, spend, and allocate capital. This in-depth guide breaks ...
A boutique fund revealed a sizable stake in a hotel stock, signaling interest in the sector’s recovery. Here’s a prac...
Howard Hanna NYC launches a major hiring spree, adding 26 agents to its Manhattan operation. The move includes the An...
Dive into veeva (veev) 2026 earnings with a close look at Q4 results, guidance, and what the numbers mean for investo...
A $1,000 stake in Nvidia a decade ago would now command a large payoff, but the ride was anything but smooth. The sto...